Unknown

Dataset Information

0

Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes.


ABSTRACT: To evaluate long-term effects of continuous glucose monitoring (CGM) in intensively treated adults with type 1 diabetes.We studied 83 of 86 individuals >or=25 years of age with type 1 diabetes who used CGM as part of a 6-month randomized clinical trial in a subsequent 6-month extension study. RESULTS After 12 months, median CGM use was 6.8 days per week. Mean change in A1C level from baseline to 12 months was -0.4 +/- 0.6% (P < 0.001) in subjects with baseline A1C >or=7.0%. A1C remained stable at 6.4% in those with baseline A1C <7.0%. The incidence rate of severe hypoglycemia was 21.8 and 7.1 events per 100 person-years in the first and last 6 months, respectively. Time per day with glucose levels in the range of 71-180 mg/dl increased significantly (P = 0.02) from baseline to 12 months.In intensively treated adults with type 1 diabetes, CGM use and benefit can be sustained for 12 months.

SUBMITTER: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group 

PROVIDER: S-EPMC2768224 | biostudies-literature | 2009 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes.

Bode Bruce B   Beck Roy W RW   Xing Dongyuan D   Gilliam Lisa L   Hirsch Irl I   Kollman Craig C   Laffel Lori L   Ruedy Katrina J KJ   Tamborlane William V WV   Weinzimer Stuart S   Wolpert Howard H  

Diabetes care 20090812 11


<h4>Objective</h4>To evaluate long-term effects of continuous glucose monitoring (CGM) in intensively treated adults with type 1 diabetes.<h4>Research design and methods</h4>We studied 83 of 86 individuals >or=25 years of age with type 1 diabetes who used CGM as part of a 6-month randomized clinical trial in a subsequent 6-month extension study. RESULTS After 12 months, median CGM use was 6.8 days per week. Mean change in A1C level from baseline to 12 months was -0.4 +/- 0.6% (P < 0.001) in subj  ...[more]

Similar Datasets

| S-EPMC9208859 | biostudies-literature
| S-EPMC3064030 | biostudies-literature
| S-EPMC6283439 | biostudies-literature
| S-EPMC7298607 | biostudies-literature
| S-EPMC6208158 | biostudies-literature
| S-EPMC6014540 | biostudies-literature
| S-EPMC2858162 | biostudies-literature
| S-EPMC10538856 | biostudies-literature
| S-EPMC7699009 | biostudies-literature
| S-EPMC7147466 | biostudies-literature